1. Introduction
===============

Periodontal disease (PD) includes a number of inflammatory-based conditions such as gingivitis and periodontitis, which are the most common infectious diseases affecting tooth-supporting bone structures. Untreated periodontitis affects more than 700 million people worldwide,^\[[@R1]\]^ can lead to tooth loss, and has been linked to conditions such as cardiovascular disease, diabetes mellitus, or obesity.^\[[@R1]\]^

Over the last 30 years, severe PD has been associated with HIV infection.^\[[@R2]\]^ Although antiretroviral therapy (ART) preserves and restores immune function and prevents the development of opportunistic infections, individuals with sustained virological suppression continue to experience an increased incidence of age-related comorbidities (including PD) with synergistic effects on survival and quality of life. The determinants, course, and impact on other comorbid conditions of severe PD in the setting of ART remain a matter of controversy.^\[[@R3],[@R4]\]^

In classical microbiology descriptions, increases in *Porphyormonas gingivalis, Treponema denticola,* and *Tannerella forsythia*, the so-called red complex, were strongly associated with destructive PD, whereas predominance of other bacterial complexes was associated to less severe PD.^\[[@R5]--[@R8]\]^ The formation of plaque in mature teeth with an enriched proportion of Gram-negative anaerobic bacteria activates pro-inflammatory pathways and promotes the formation of periodontal pockets. These pockets allow for the local accumulation of anaerobic bacteria, against which the host response is inefficient and even counter-productive. With the arrival of new sequencing technologies, periodontitis has been linked to a broader disbyosis in the oral microbiome, initiated by changes in key pathogenic species with a context of accessory pathogens and their expression profiles. These changes promote a proinflammatory community and can trigger tissue destruction augmented by the host immune response.^\[[@R9]--[@R16]\]^

To date, research on the interplay between HIV infection, the oral microbiome, and PD has produced inconclusive results. A small study in children with only 5 HIV-negative controls found no evident differences in the oral microbiome composition between well-controlled HIV-positive and HIV-negative children.^\[[@R17]\]^ In comparison, 15 subjects with AIDS attending HIV clinics in China showed significant increases in several bacteria, and a distinct salivary bacterial profile between necrotic and chronic PD.^\[[@R18]\]^ Using a microbial microarray, there were significant differences in the salivary bacterial composition between HIV-positive subjects before and after ART initiation and between them and HIV-negative adults.^\[[@R19]\]^ Moreover, an independent study revealed increased diversity in subgingival biofilms of HIV+ individuals within a Brazilian cohort of 32 subjects with PD.^\[[@R20]\]^

Here, we sought to characterize how HIV infection and other related factors modulate oral microbiome communities in different PD states using high throughput technologies and also identify specific oral microbiome markers of HIV infection.

2. Methods
==========

2.1. Study design
-----------------

This was a cross-sectional study including both HIV+ and HIV-- participants with varying degrees of PD. HIV+ patients were recruited in the Oral Health Center of Infectious Disease Program at Grady Memorial Hospital located in Atlanta, GA. HIV-1 infection was documented by ELISA and confirmed by Western blot at any time prior to study entry. HIV-- control samples were obtained from clinical and research staff at the same institution. HIV-- participants were required to demonstrate HIV seronegativity in the prior 30 days before inclusion in the study by HIV free testing at the Infectious Disease Program Ponce Clinic.

PD was assessed by the oral exam using the Centers for Disease Control/merican Academy of Periodontology (CDC/AAP) criteria based on the tooth clinical attachment level (CAL) and the probing pocket depth (PPD):^\[[@R21]\]^(1)Severe PD (S-PD): both \>2 interproximal sites with CAL \>6 mm and \>1 interproximal site with PPD \>5 mm.(2)Moderate PD (M-PD): either \>2 interproximal sites with CAL \>4 mm or \>2 interproximal site with PPD \>5 mm.(3)Mild/none PD (N-PD): neither S-PD nor M-PD.

Exclusion criteria included: (A) fewer than 20 teeth in the oral cavity, (b) need for antibiotic prophylaxis for more than 12 hours prior to dental care as per the current American Dental Association guidelines or use of an antibiotic in the 14 days prior to the study visit, (c) use of an antimicrobial mouth rinse (0.12% chlorhexidine gluconate) 30 days prior to the study visit, (d) use of teeth whitening in the 30 days prior to the study visit, and (e) treatment of periodontal disease in the 30 days prior to the study visit. HIV+ patients were stratified by PD severity, whereas HIV-- patients were only stratified at the analysis stage due to the limited number of controls available.

2.2. Sample collection
----------------------

Each participant had data abstracted from the medical record at the time of enrolment which included demographics, date of HIV diagnosis, opportunistic infections, laboratory values including CD4 counts and HIV viral load levels, serologic status, major clinical events including hospitalizations and surgeries, antiretroviral history including adverse events to medications and other co-morbidities, lipids, hemoglobin A1C, HIV-associated conditions (infections, neoplasms, etc), other medical conditions (diabetes, hyperlipidemia), and recent antimicrobial use. In addition, whole blood was obtained from half of the participant for immune activation analysis.

Saliva, cheek mucosa, and teeth specimens were obtained from all participants and stored at --80°C. DNA was extracted within a week and stored at --20°C prior to 16 seconds gene amplification. A curette was used to obtain dental plaque samples from whole teeth, 1 posterior molar, and 1 anterior incisor, in all participants. In participants with PD, samples were taken from the deepest periodontal pocket of teeth that was representative of the participant PD severity. Finally, 2 cheek samples were obtained from each participant. One sample was obtained from the right cheek, and 1 sample was obtained from the left cheek.

Participants were also administered a semistructured questionnaire which assessed demographic data, HIV serostatus, antiretroviral use, oral health behaviors (brushing, flossing), tobacco/illicit drug/alcohol use, diet, use of antimicrobial mouth rinses, dental prosthetic devices or teeth whitening, prior oral/dental history, and utilization of dental care services (number of visits). A dental exam was performed on each participant to assess the missing, decayed, filled (MDF) index, CAL and PPD measurements and to identify other oral cavity conditions or diseases. Finally, a measure of xerostomia was performed involving pH and salivary flow rate measurements.

2.3. DNA extraction, 16 s rRNA gene amplification, and sequencing
-----------------------------------------------------------------

Genomic DNA from all samples was extracted utilizing the MoBio PowerSoil DNA Isolation Kit (Cat \# 12888--50) and quantified via Quant-iT PicoGreen dsDNA Assay (Cat \# P11496). The 16 s V4 region was amplified through 30 cycles PCR with an F515 locus-specific primer (5′-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG-3′) and an 806R-locus specific primer (5′-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAG-3′) both with compatible overhang regions for index attachment.^\[[@R22]\]^ PCR cleanup was performed using Agencourt AmpureXP magnetic beads (Cat \# A63880). V4 fragments for all samples were indexed utilizing a second PCR reaction with Illumina Nextera Index XT Kit (Cat \# FC-121--1012) and index-adhering primers (1.1: 5′-AATGATACGGCGACCACCGAGAT-3′; 2.1: 5′-CAAGCAGAAGACGGCATACGA-3′). Indexed fragments were purified with Ampure XP beads, quantified with dsDNA Picogreen, and pooled with respect to achieving equal molecular concentrations for all samples in the final library. About 250 paired-end sequencing was performed on the MiSeq platform using an Illumina MiSeq Version 2 500-cycle Kit (Cat \# MS-102--2003) at a loading concentration of 10 picomolar. An Illumina PhiX control (Cat \# FC-110--3001) was utilized in all MiSeq runs as recommended in the MiSeq System User Guide for metagenomic samples.

2.4. Data analysis
------------------

Sequence data were quality filtered with trimmomatic.^\[[@R23]\]^ Eight out of 250 (3%) samples (that were represented by less than 1000 sequence counts) were discarded. Mothur phylotype pipeline^\[[@R24]\]^ and SILVADB^\[[@R25]\]^ /GreenGenes^\[[@R26]\]^ databases were used to classify sequences at the genus level. Alpha diversity and richness multiple group comparisons were performed using rank based Mann Whitney or Kruskal--Wallis test combined with post-hoc Nemenyi test implemented in PMCMR R^\[[@R27]\]^ packages. For taxonomical analysis, R/Bioconductor (Vegan,^\[[@R28]\]^ PhyloSeq,^\[[@R29]\]^ and DESeq2)^\[[@R30]\]^ software packages were used. Richness and diversity were estimated using Chao1 and Shannon estimators respectively as implemented in the Vegan package. Principal Coordinates Analysis (PCoA) and weighted Unifrac distances were used for unconstrained ordination on genus proportions. Adonis was used to assess overall microbiome structure differences between defined groups. A negative binomial fit and Wald test were run on every genus to assess differential abundance. *P*-values were adjusted using the Benjamini--Hochberg correction.^\[[@R31]\]^

To predict the functional composition of the oral microbiome from 16S data, we used PICRUSt.^\[[@R32]\]^ First, the phylotype table obtained by Mothur/GreenGenesDB was normalized by dividing the abundance of each organism by its predicted 16S copy number (script normalize_by_copy_number.py). To infer the gene content (script predict_metagenomes.py), the normalized phylotype abundances were multiplied by the respective set of gene abundances (represented by KEGG identifiers) estimated for each taxon. The gene content table obtained was used to analyze the metabolic pathways represented at different KEGG level categories structured in 3 hierarchical levels, using HUMAnN.^\[[@R33]\]^ Finally, we identified putative biologically relevant pathways that characterized the different sites, HIV status and PD states by applying the LEfSe algorithm.^\[[@R34]\]^

2.5. Polychromatic flow cytometry
---------------------------------

Flow cytometry and Boolean analysis were performed as previously described^\[[@R35],[@R36]\]^ with a few modifications. Briefly, 2 million peripheral blood mononuclear cells were re-suspended in 100 μL of RPMI plus 10% fetal bovine serum (FBS) in a 5 mL polypropylene tube. Cells were washed once with cold phosphate-buffered saline (PBS) containing 2% FBS, surface stained at room temperature for 30 minutes with antibodies specific to human CD4, CD3, CD8, HLA-DR, and CD38 each conjugated to a different fluorophore. Cells were fixed with cytofix/cytoperm (BD Pharmingen) and permeabilized with 1X permwash (BD Pharmingen). Cells were then incubated with antihuman Ki-67 antibody conjugated to a different fluorochrome for 30 minutes at 4°C. Cells were washed twice with 1 X Permwash, once with 2% Fetal bovine serum(FBS) in phosphate buffered saline (PBS and re-suspended in 1% formalin in PBS. Cells were acquired on the LSRII (BD Immunocytometry systems) and analyzed using the FlowJo software (Treestar, Inc., San Carlos, CA). Lymphocytes were identified based on their scatter pattern, and CD3+, CD8-, CD4+ cells were considered as CD4 T cells, whereas CD3+, CD8+, CD4- cells were considered as CD8 T cells. CD38+, HLA-DR+ or Ki-67+ T cells were further defined on total CD4 or CD8 T cells. Using the CD38, Ki-67 and HLA-DR gates, a Boolean analysis was performed to calculate the frequencies of the 7 different combinations of subsets using the Flowjo software.

Correlation between every bacterial genus/PCoA axis and immune markers was performed through the fit of a linear model for each combination of immune marker. The Benjamini--Hochberg^\[[@R31]\]^ method was used for adjustment of multiple comparisons error.

2.6. Ethics approval and consent to participate
-----------------------------------------------

The study was approved by the Emory University IRB under the title "The Oral Metagenomics Study" (IRB00048095). All participants provided informed consent.

3. Results
==========

This was a cross-sectional study including 50 participants. Participant population characteristics and dental exam information are shown in Table S1a, S1b, and S1c, respectively. Each participant contributed saliva, tooth samples from 2 teeth, and 2 cheek mucosa samples. Of these participants, 40 (80%) were HIV+. Only one of these participants was ART naive. Only 8 of the total participants had a detectable viral load, and 3 of these 8 had a viral load that was less than 1000 copies per mL. Although HIV+ participants tended to be homosexual older men compared to the HIV-- participants, the study population was well balanced with regard to PD status. A total of 18 (36%), 16, and 16 (32%) of the participants presented none/mild (N-PD), moderate (M-PD), and severe (S-PD) PD, respectively. There were no significant differences in the salivary flow rate, MDF (missing, decayed, filled teeth), or salivary buffering capacity between N and M/S-PD participants. 242 of the samples provided more than 1000 sequences and were used for downstream analyses. Of these, 94/100, 49/50, and 99/100 were cheek, saliva, and teeth samples, respectively. A total of 148/408 (36.3%) different bacterial genera provided more than 100 counts and were kept for further analyses.

3.1. Microbiome analysis
------------------------

When all sample sites were analyzed together, bacterial diversity but not richness was consistently higher in tooth samples than in both cheek and saliva samples through all PD stages and in both HIV-positive and -negative participants (*P* \< 0.001 for all comparisons, Fig. [1](#F1){ref-type="fig"} and Fig. S1). Importantly, greater similarity was found in the same participant teeth and cheek samples (Fig. S6) than between participants. Alpha diversity measures regarding HIV infection were less consistent. HIV-- samples showed higher richness measures only in the M-PD group (*P* \< 0.05), whereas this tendency was reversed in diversity for the S-PD group (*P* \< 0.01). Additionally, S-PD was associated with higher richness and diversity measures, but only in cheek samples.

![Richness (observed species, Chao1 indices) and diversity (Shannon and Simpson indices) for different sampling sites by HIV infection status (A), HIV infection status by sampling site (B), and by PD and HIV infection status (C). HIV = human immunodeficiency virus, PD = periodontal disease.](medi-96-e5821-g001){#F1}

PCoA ordination analyses showed a clear differentiation of microbial structure among body sites sampled (adonis test *P* value = 0.001, *R*2 = 0.20, Fig. [2](#F2){ref-type="fig"}), whereas HIV status and PD severity showed a statistically significant but marginal contribution to microbial structure differentiation (HIV: adonis *P* value = 0.008, *R*2 = 0.01, PD: adonis *P* value = 0.092, *R*2 = 0.01, Fig. S2), which was of similar magnitude to that of ethnicity (EthnicGroup adonis *P* value =  \< 0.005, *R*2 = 0.03) and sexual behaviour (SexBeh, adonis *P* value = \<0.05, *R*2 = 0.02). According to stratified analysis these factors lost statistical significance on saliva, but not for cheek and teeth samples, whereas habits such as tobacco (adonis *P* value = \<0.05, *R*2 = 0.05) and soda drink (adonis *P* value = \<0.05, *R*2 = 0.06) consumption became statistically relevant. Ethnicity had the largest effect on teeth (adonis *P* value\< = 0.01, *R*2 = 0.07) and cheek (adonis *P* value\< = 0.001, *R*2 = 0.17) samples. Importantly, PD effects on oral microbiome were only significant for cheek (adonis *P* value\< = 0.01, *R*2 = 0.06) but not for teeth or saliva samples, whereas HIV infection exerted a similar effect on cheek (adonis *P* value = 0.05, *R*2 = 0.02) and teeth samples (adonis *P* value\<0.01, *R*2 = 0.03) but had no significant impact in saliva samples.

![PCoA ordination analysis. Axes 1 and 2 capture 58% of the variance observed in the microbiome structure of all oral samples. According to PERMANOVA analysis, sampling site explained 20% of the oral microbiome structure (adonis test *P* value = 0.001, *R*2 = 0.20). 10% was evenly explained by other factors such as HIV infection (adonis test *P* value = 0.001, *R*2 = 0.01), ethnicity (adonis test *P* value = 0.001, *R*2 = 0.03), sexual behaviour (adonis test *P* value = 0.006, *R*2 = 0.02) and periodontal disease severity (adonis test *P* value = 0.003, *R*2 = 0.02). HIV = human immunodeficiency virus, PCoA = principal coordinates analysis.](medi-96-e5821-g002){#F2}

*Firmicutes* was the most abundant phylum in all sampling sites followed by *Actinobacteria*, *Bacteroidetes*, *Fusobacteria,* and *Proteobacteria*, whose relative abundance order changed depending on sampling site (Fig. S3). Differences linked to HIV infection affected the *Proteobacteria* phylum, which was overabundant in HIV+ cheek (log 2 Fold-Change (log 2 FC)):1.08, *P*~adj~\<0.0051) and teeth samples (log2FC:1.23, *P*~adj~\<0.005),(Table S2) although there was no correlation of *Proteobacteria* abundance with viral load (VL) or CD4+ counts within the HIV-positive group (data not shown). Changes in phylum abundance with PD severity were more frequent. *Synergistetes* and *Spirochaetae*, both low abundant phyla, were consistently found to be more abundant in teeth, cheek, and saliva samples from the S-PD group versus N-PD, whereas *Proteobacteria* and *Firmicutes* phyla had a 2-fold reduction in cheek and saliva, but not in teeth S-PD affected samples.

HIV infection status was also associated with relative abundance changes of different bacterial genera. In particular, *Neisseria* and genera of the unclassified *Neisseriaceae* family were 4-fold more abundant in samples from HIV+ participants (log 2 FC = 1.84, *P*~adj~ \< 0.001, Table [1](#T1){ref-type="table"} and Fig. [3](#F3){ref-type="fig"}). Interestingly, this change in abundance was consistent through the different anatomical sites, although with different levels of significance as well as in the age and sexual behavior adjusted model (Table S5). Importantly, the *Neisseria* genus was also more abundant in samples from HIV+ participants through varying severity of PD, with similar fold-change values (log 2 FC) with respect to HIV-- samples (see Table S3 & S4). Interestingly, *Aggregatibacter* genus abundance was higher in HIV+ N-PD samples (log 2 FC = 2.02, *P*~adj~ \< 0.005), but not in more advanced PD stages. Furthermore, 3 different genera (*Abiotrophia*, *Rothia* and unclassified *Pasteurellaceae)* that were uniquely enriched in cheek HIV+ N-PD samples, were otherwise overabundant in M-PD and S-PD teeth, but not saliva samples, suggesting a tissue shift of these genera along PD severity (Table S4). Other genera were found to be differentially abundant in either HIV+ teeth, saliva or cheek samples, but not generally, in such a way that HIV associated changed in microbial genera were found to be localized to single site/PD severity combinations.

###### 

Genus level significant changes in abundance associated with HIV infection (HIV+) stratified by severity of PD.

![](medi-96-e5821-g003)

![Classified differential abundant genera between HIV+ and HIV-- samples. Log 2 Fold Change is plotted on the *X*-axis. Phyla is indicated using color codes. Point size indicates the mean count for a particular genus on the whole sample set. HIV = human immunodeficiency virus.](medi-96-e5821-g004){#F3}

Of the bacterial genera that are traditionally linked to PD^\[[@R6]\]^ only *Treponema* genus was found to be overabundant in S-PD when compared to N-PD, when HIV infection was not considered, in both cheek (log 2 FC = 1.83, *P*~adj~ \< 0.005) and saliva (log 2 FC = 2.6, *P*~adj~ \< 0.001) samples, albeit in very low abundance (Table [1](#T1){ref-type="table"}). These were accompanied by other genera, underlining the complex multicomponent nature of microbiome disbyosis with PD. Cheek samples showed the greatest number of differentially abundant bacterial genera along PD severity. Severe PD was associated, with a 2-fold reduction in highly abundant *Streptococcus*, *Veillonella* genera, and unclassified *Pasteurellaceae* family, whereas the 2 latter also showed similar under-abundance in saliva samples. Interestingly, the *Neisseria* genus was not found to be over- or under-represented in different PD stages.

3.2. Immune activation
----------------------

Immune activation markers were available for a subset of 24 participants (8 N-PD, 8 M-PD, and 8 S-PD), whereas CD4 counts were only available for the subset of HIV-positive participants. Despite the fact most HIV-positive participants were receiving ART (see Table S1c), there was a strong association between HIV infection and immune activation, proliferation, and translocation markers (Fig. [4](#F4){ref-type="fig"}). This association was also found for CD4+ T cell counts and PD severity, showing a higher CD4+ count in N-PD participants, indicating a deterioration of the immune system both with moderate or severe PD. Interestingly, immune markers for proliferation were found to be higher both for the CD8 and CD4 T-cell subset in moderate M-PD than in both N-PD and S-PD, whereas markers for cell activation were not significantly differently across PD severity.

![Immune activation, proliferation, and bacterial translocation markers according to the HIV infection and the PD stage. *Y*-axis values for immune markers represent proportion of CD4/CD8 population resulting of the gate strategy described in the plot title. CD4+ T-cell counts were unavailable for HIV-- subjects. HIV = human immunodeficiency virus, PD = periodontal disease.](medi-96-e5821-g005){#F4}

Immune activation markers were correlated with both genus abundance and projection of each of the samples against each of the first 3 ordination PCoA axes from the analysis segregated by sampling. A strong and significant correlation was found between HLA-DR+/Ki67+/CD38- cell subset and increasing abundance of *Streptococcus* genus (*R*2 = 0.61, *P*~adj~ (FDR)\<0.001, Fig. S4), only in saliva samples. In addition, none of the immune activation markers nor CD4+ T cell counts showed a significant correlation with any of the PCoA axes (data not shown) in any sampling site type. Interestingly, a 4-fold depletion of the *Streptococcus* genus was associated with HIV+ status in cheek S-PD samples. Although this depletion in cheek samples was not accompanied by significant changes in teeth or saliva S-PD samples, there was a general and significant trend towards *Streptococcus* depletion globally in S-PD HIV+ participants, whereas this genus was enriched in N-PD HIV+ participants.

3.3. Functional analysis
------------------------

Functional analysis using the PiCRUSt inferred gene content also revealed major differences among sampling sites (Fig. S5). Teeth samples were enriched in cell motility pathways including chemotaxis and flagellar assembly, probably reflecting tooth biofilm formation. Genes within carbohydrate, vitamins, and lipid metabolism pathways were enriched in cheek samples. No significant differences in the functional gene content could be consistently linked to HIV infection in any PD severity or anatomic site. In combination with taxonomical analysis and the lack of correlation between HIV-linked bacterial genera and inflammation, this underlines the nonpathogenic character of the increased abundance of *Neisseria* genus and suggests the pathobiont nature of this genus in the context of HIV-associated PD.^\[[@R37]\]^

4. Discussion
=============

This study adds important information to the paucity of publications examining the effect of HIV status on the human oral microbiome. As reported in other studies, major differences in microbiome structure and composition were associated with the anatomic sampling site of patients, underscoring the great diversity and biogeography within the oral microbiome.

Globally, PD severity was associated with a broader change within the oral microbiome than HIV infection. PD affected a high number of bacterial genera, and these changes were of greater magnitude due to the mean abundance of affected genera and showed specificity for the sampling site. For instance, *Veillonella* and *Streptococcus,* both dominant genera in cheek mucosa and saliva, had a 2-fold reduction, thus contributing to alpha-diversity increases detected in these 2 sampling sites with PD severity. In addition, low-abundant members of the *Treponema* genus belonging to the PD-associated red complex were also enriched in severe PD samples. Conversely, differences in *Tannerella* and *Porphyromonas* genera along PD were not observed in this dataset. In our study, these genera were found at very low abundances (0.2% and 2.3%, mean abundances, respectively) in teeth and not differentially abundant along PD severity. Interestingly, Hong et al described 2 types of microbial communities in a PD-affected general population. Only one of them was enriched in *Tannerella* and *Porphyromonas* and associated to PD severity.^\[[@R38]\]^ Our results may indicate that HIV infection may result in a bias in the dysbiotic pathway toward PD.

HIV infection solely affected a few low-abundance bacterial genera, including *Neisseria,* which was 4-fold enriched in 3 independent oral sampling sites. The *Neisseria* genus has been previously found to be depleted in the subgingival plaque of smokers,^\[[@R39]\]^ whereas other sampling sites have not been explored to this respect. In our dataset, smoking also had a depleting effect in the 3 different sampling sites. Although it cannot be absolutely ruled out that other confounding factors may be affecting our results, our study design was well-balanced and no significant interaction between smoker status and HIV infection was detected. Furthermore, the *Neisseria* genus enrichment was still associated with HIV infection in the nonsmoker subset (log 2 FC = 1.48, *P*~adj~\<0.05), although statistical significance was marginally lost for the smoker smaller subset (log 2 FC = 1.1, *P*~adj~ = 0.15). Also, sexual behavior has been linked to changes in the gut microbiome.^\[[@R40]\]^ Although, in our dataset, HIV infection was enriched in men who had sex with men, this factor alone had a small effect on the oral microbiome structure (adonis test *R*2 = 0.02, Pr (\>*F*) = 0.032) and the age and sexual behavior adjusted model provided a similar picture in bacterial differential abundance than the unadjusted one. Several species that belong to the *Neisseria* genus such as *N bacilliformis* and *N elongata*, considered as nonpathogenic^\[[@R41],[@R42]\]^ or related to PD,^\[[@R16]\]^ have been associated with respiratory and oral cavity infections.^\[[@R43]\]^ The role of oral *Neisseria* genus in HIV infection has attracted limited attention; the few published studies using distinct sampling techniques had contradictory results. Recently, *N. elongata* was found to be enriched in the salivary microbiome of AIDS patients,^\[[@R18]\]^ but minor nonsignificant changes in this genera were found between HIV-positive participants before and after commencing ART and when compared to seronegative participants in another study.^\[[@R19]\]^ In addition, colonization of *N flavescens* was lower in the lingual microbiome of HIV-positive patients receiving ART than in HIV-negative controls.

Of note, no relation between *Neisseria* and *Neisseriaceae* family abundance and immune activation markers could be detected. This could be explained both by the commensal nonpathogenic nature of *Neisseria* genus and by a potential competitive advantage in HIV+ participants that affected all sampling sites, even under ART.

5. Conclusions
==============

PD and HIV infection were associated with significant microbiome changes within anatomic sampling sites. Three major findings were uncovered in this analysis: (1) *Neisseria* spp. appeared to be enriched in HIV-positive participants compared to HIV-negative participants across all sampling sites, (2) among HIV+ participants *Abiotrophia*, *Rothia,* and unclassified *Pasteurellaceae* were enriched in M-PD and S-PD compared to N-PD, and (3) *Treponema* spp. were enriched in S-PD compared to N-PD for all participants. PD moderate severity was associated with higher CD4 and CD8 proliferation; however, associations with other inflammatory parameters relevant for HIV pathogenicity were not found.

Although *Neisseria* genus was found to be enriched in the oral microbiome of HIV-positive participants, it showed no linkage to either inflammation, immune parameters, or functional gene content. Relative abundance increase was consistently found in teeth, cheek mucosa, and saliva samples and in samples from participants with mild or no PD, but also moderate and severe PD. Changes in other bacterial genera related to HIV infection were scarce and had a very limited effect on bacterial diversity.
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